Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S beta5-subunit.

The Biochemical Journal
Christopher BlackburnJonathan L Blank

Abstract

The mammalian 26S proteasome is a 2500 kDa multi-catalytic complex involved in intracellular protein degradation. We describe the synthesis and properties of a novel series of non-covalent di-peptide inhibitors of the proteasome based [corrected] on a capped tri-peptide that was first identified by high-throughput screening of a library of approx. 350000 compounds for inhibitors of the ubiquitin-proteasome system in cells. We show that these compounds are entirely selective for the beta5 (chymotrypsin-like) site over the beta1 (caspase-like) and beta2 (trypsin-like) sites of the 20S core particle of the proteasome, and over a panel of less closely related proteases. Compound optimization, guided by X-ray crystallography of the liganded 20S core particle, confirmed their non-covalent binding mode and provided a structural basis for their enhanced in vitro and cellular potencies. We demonstrate that such compounds show low nanomolar IC50 values for the human 20S beta5 site in vitro, and that pharmacological inhibition of this site in cells is sufficient to potently inhibit the degradation of a tetra-ubiquitin-luciferase reporter, activation of NFkappaB (nuclear factor kappaB) in response to TNF-alpha (tumour necrosis factor-alpha...Continue Reading

References

Feb 26, 1998·Cell·W BaumeisterE Seemüller
Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·J AdamsR L Stein
Nov 4, 2000·Nature Structural Biology·M GrollD Finley
Mar 27, 2001·Nature Reviews. Molecular Cell Biology·P M Kloetzel
Jun 8, 2001·Bioorganic & Medicinal Chemistry Letters·C García-EcheverríaP Furet
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
May 17, 2002·Structure·Masaki UnnoTomitake Tsukihara
Nov 1, 2002·Molecular Cell·David S LeggettDaniel Finley
Jun 24, 2003·Nature Medicine·Gary D LukerDavid Piwnica-Worms
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Jul 2, 2003·Acta Crystallographica. Section D, Biological Crystallography·Elizabeth PottertonEleanor Dodson
Mar 3, 2004·Nature Reviews. Molecular Cell Biology·Cecile M Pickart, Robert E Cohen
Jul 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexander W Schüttelkopf, Daan M F van Aalten
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Sep 17, 2004·Journal of Medicinal Chemistry·Pascal FuretCarlos García-Echeverría
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Nov 9, 2005·Methods in Enzymology·Michael Groll, Robert Huber
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Andrew G W Leslie
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Peter M Voorhees, Robert Z Orlowski
Jan 18, 2006·Annual Review of Medicine·Paul G RichardsonKenneth C Anderson
Sep 27, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherAndré Goy
Dec 19, 2006·Molecular Cancer Therapeutics·Mark J WilliamsonMark Rolfe
Feb 24, 2007·Chemical Reviews·Ljudmila Borissenko, Michael Groll
May 22, 2007·Journal of Medicinal Chemistry·Nicolas BasseJoëlle Vidal
Mar 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert Z Orlowski, Deborah J Kuhn
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Dec 26, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Michael GrollLuis Moroder
Apr 11, 2009·Nature·Teresa A SoucySteven P Langston
Mar 1, 2006·International Journal of Peptide Research and Therapeutics·Carlos García-Echeverría

❮ Previous
Next ❯

Citations

May 21, 2013·Cell Biochemistry and Biophysics·Adam T MelvinNancy L Allbritton
Feb 11, 2012·ACS Combinatorial Science·Christopher Blackburn
Apr 4, 2013·Journal of Medicinal Chemistry·Sevil OzcanSaïd M Sebti
Dec 11, 2013·European Journal of Medicinal Chemistry·Makoto HasegawaTamio Mizukami
Feb 21, 2014·Biochemical Pharmacology·Denise NiewerthJacqueline Cloos
May 6, 2014·Archives of Toxicology·Sara Rodríguez-EnríquezRafael Moreno-Sánchez
Jan 21, 2014·Antioxidants & Redox Signaling·Guillem Paniagua SorianoBogdan I Florea
Apr 4, 2013·Expert Opinion on Drug Discovery·Yuri PevznerKenyon Daniel
Jun 1, 2014·Expert Opinion on Drug Discovery·Chiara PautassoAntonio Palumbo
Jan 8, 2016·Annual Review of Pharmacology and Toxicology·Paweł Śledź, Wolfgang Baumeister
Oct 19, 2016·Immunology and Cell Biology·Gagandeep Kaur, Sanjay Batra
Mar 4, 2014·Medicinal Research Reviews·Nicola MicaleMaria Zappalà
Mar 23, 2012·Chembiochem : a European Journal of Chemical Biology·Luigi MargarucciAgostino Casapullo
Dec 6, 2014·Chembiochem : a European Journal of Chemical Biology·Kimberly Cornish CarmonyKyung-Bo Kim
May 31, 2018·Angewandte Chemie·Stefano AgnelloRainer Riedl
Nov 21, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yousef SalamaBeate Heissig
Apr 17, 2019·Protein Engineering, Design & Selection : PEDS·Wenting ZhaoLaura Segatori
Jan 24, 2019·Journal of Cancer Prevention·Ho Hee Jang
Feb 2, 2019·Current Pharmaceutical Design·Gulce SariBetul Karademir
Feb 12, 2019·Chembiochem : a European Journal of Chemical Biology·Christine S MuliDarci J Trader
Nov 1, 2011·Chemical Communications : Chem Comm·Melissa Ann Gräwert, Michael Groll
Oct 17, 2017·British Journal of Pharmacology·Michael BaslerMarcus Groettrup
Nov 23, 2011·Angewandte Chemie·Nerea GallasteguiMichael Groll
Jul 10, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael BaslerMarcus Groettrup
Dec 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Esilida Sula KarreciJamil Azzi
Nov 17, 2019·International Journal of Molecular Sciences·Romina A GuedesRita C Guedes
Feb 27, 2014·The Journal of Biological Chemistry·Aslamuzzaman KaziSaïd M Sebti
Mar 3, 2012·Chembiochem : a European Journal of Chemical Biology·Alban R PereiraWilliam H Gerwick

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
transfection
gel filtration
transfections
ubiquitination

Software Mentioned

CCP4i
Coot
PRODRG
PyMOL Molecular Graphics System
iMOSFLM
SCALA
REFMAC

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.